10
Participants
Start Date
January 31, 2014
Primary Completion Date
September 30, 2017
Study Completion Date
September 30, 2017
Gabapentin
"Gradually increasing doses of medication from 100 mg on day 1 to 300 mg twice a day on day 6. On day 7, the patient received a 300-mg dose from the day 7 envelope, about two hours after a light breakfast and 1 hour before data collection. The relatively low dose and gradual titration were selected to enhance compliance and reduce adverse effects, based on a rectal mechanosensitivity study."
Lead Sponsor
Medstar Health Research Institute
OTHER